Aktiv has developed a range of prefilled drug delivery systems based on ARCH - a glass-free container closure system made from high performance barrier films.

The ARCH portfolio and IP include a substitute to vials, prefilled syringes, internasal delivery system, on-body injectors, and IV transfer systems.

The leading product in the ARCH portfolio is ARCH-Vial, developed under a collaboration with a leading biopharmaceutical company as a single-dose presentation for mRNA vaccines and therapeutics. Supporting data includes stability data (mRNA integrity, pH), cryogenic temperatures endurance, and freeze-thaw cycling.

Effective solution for biologics that have compatibility issues with traditional glass vials and syringes.

Option for dual-chamber reconstitution configuration.

The product allows for highly cost-efficient, high-speed manufacturing and a simplified fill-finish process, with minimal overfill and drug wastage.

ARCH simplifies the drug delivery process, streamlining healthcare professionals’ operation with its self-contained, 3-step system that also opens the door for patient self-administration at home. ARCH containers have less than 50% the carbon footprint of glass vials.